Invitation to presentation in connection with EQL Pharma's year-end report, fourth quarter, 2022/23
EQL Pharma AB (publ) will publish its year-end report for the fourth quarter, 2022/23, on Thursday, May 11[th], before stock markets opening.At 10.00 (CET) 11[th] May, the company will give a presentation via video conference. The presentation is aimed at shareholders and potential shareholders. CEO and President Axel Schörling presents and comments on the year-end report. After the presentation, there is an opportunity to ask questions for those who participate. Use the following link to access the virtual meeting: https://tinyurl.com/ttvtm8rp Date and time May 11[th], 2023, at 10.